Jeff White

1.6k total citations
53 papers, 898 citations indexed

About

Jeff White is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jeff White has authored 53 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Jeff White's work include Testicular diseases and treatments (18 papers), Sarcoma Diagnosis and Treatment (10 papers) and Neuroblastoma Research and Treatments (8 papers). Jeff White is often cited by papers focused on Testicular diseases and treatments (18 papers), Sarcoma Diagnosis and Treatment (10 papers) and Neuroblastoma Research and Treatments (8 papers). Jeff White collaborates with scholars based in United Kingdom, United States and Belgium. Jeff White's co-authors include James Carmichael, Peter W. Hewett, Thomas A. McCulloch, Dennis Kosuge, Berndt Enholm, Chris Twelves, Ian Judson, J Cassidy, Charlotte Benson and Robin Reid and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Jeff White

48 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff White United Kingdom 16 363 332 279 209 89 53 898
Albiruni Ryan Abdul Razak Canada 18 661 1.8× 410 1.2× 375 1.3× 257 1.2× 47 0.5× 100 1.3k
Yoshito Yamashita Japan 21 409 1.1× 229 0.7× 529 1.9× 562 2.7× 156 1.8× 111 1.4k
Jey-Hsin Chen United States 6 481 1.3× 269 0.8× 256 0.9× 104 0.5× 46 0.5× 11 1.1k
Yangsoon Park South Korea 20 475 1.3× 279 0.8× 390 1.4× 301 1.4× 72 0.8× 59 1.2k
Niall Swan Ireland 18 453 1.2× 702 2.1× 248 0.9× 322 1.5× 27 0.3× 59 1.4k
Hideya Takeuchi Japan 17 584 1.6× 371 1.1× 358 1.3× 223 1.1× 98 1.1× 70 1.3k
Antonio De Leo Italy 17 228 0.6× 191 0.6× 230 0.8× 164 0.8× 88 1.0× 101 869
Takumi Shimomatsuya Japan 14 387 1.1× 470 1.4× 285 1.0× 302 1.4× 46 0.5× 51 1.0k
Chueh‐Chuan Yen Taiwan 19 386 1.1× 203 0.6× 377 1.4× 221 1.1× 105 1.2× 58 930
Cristian Lolli Italy 19 578 1.6× 274 0.8× 761 2.7× 263 1.3× 236 2.7× 88 1.4k

Countries citing papers authored by Jeff White

Since Specialization
Citations

This map shows the geographic impact of Jeff White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff White more than expected).

Fields of papers citing papers by Jeff White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff White. The network helps show where Jeff White may publish in the future.

Co-authorship network of co-authors of Jeff White

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff White. A scholar is included among the top collaborators of Jeff White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff White. Jeff White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffman, Sarah R., Stephan Lanes, Jeff White, et al.. (2025). Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐1‐ RAs ) in Type 2 Diabetes and Chronic Weight Management: A Real‐World Data Study. Pharmacoepidemiology and Drug Safety. 34(9). e70214–e70214.
3.
Eckbo, Eric, et al.. (2024). Severe hypercalcemia as a result of disseminated Candida krusei infection. International Journal of Infectious Diseases. 140. 110–112. 2 indexed citations
4.
Morfouace, Marie, Peter Horak, Simon Kreutzfeldt, et al.. (2022). Comprehensive molecular profiling of sarcomas in adolescent and young adult patients: Results of the EORTC SPECTA-AYA international proof-of-concept study. European Journal of Cancer. 178. 216–226. 7 indexed citations
5.
Shamash, Jonathan, Shah‐Jalal Sarker, Robert Huddart, et al.. (2017). A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3). Annals of Oncology. 28(6). 1333–1338. 15 indexed citations
6.
Harrington, Jennifer & Jeff White. (2017). The late medical effects of cancer treatments: a growing challenge for all medical professionals. Clinical Medicine. 17(2). 137–139. 1 indexed citations
7.
Dunlop, Cheryl E., Brian M. Brady, Marie Mclaughlin, et al.. (2016). Re-implantation of cryopreserved ovarian cortex resulting in restoration of ovarian function, natural conception and successful pregnancy after haematopoietic stem cell transplantation for Wilms tumour. Journal of Assisted Reproduction and Genetics. 33(12). 1615–1620. 27 indexed citations
8.
9.
Gill, Anthony J., et al.. (2014). Performance of formulae based estimates of glomerular filtration rate for carboplatin dosing in stage 1 seminoma. European Journal of Cancer. 50(5). 944–952. 21 indexed citations
10.
Huddart, Robert, Rhian Gabe, Fay Cafferty, et al.. (2014). A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604). European Urology. 67(3). 534–543. 20 indexed citations
11.
Bulusu, V.R., John Fullarton, Michael Leahy, et al.. (2013). Rationale and design of a UK database for a rare cancer type: the GEM Registry for gastrointestinal stromal tumours. British Journal of Cancer. 109(6). 1403–1407. 5 indexed citations
12.
Horák, Jiří, Jeff White, Adrian L. Harris, et al.. (2011). The effect of different etiologies of hepatic impairment on the pharmacokinetics of gefitinib. Cancer Chemotherapy and Pharmacology. 68(6). 1485–1495. 25 indexed citations
13.
Rimmer, Y., John Chester, Dan Stark, et al.. (2011). Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour. British Journal of Cancer. 105(6). 766–772. 11 indexed citations
14.
Benson, Charlotte, Jeff White, Johann S. de Bono, et al.. (2006). A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. British Journal of Cancer. 96(1). 29–37. 221 indexed citations
15.
Waterston, Ashita, Morag Seywright, & Jeff White. (2006). A salutary tale of mistaken identity in testicular cancer. Urologic Oncology Seminars and Original Investigations. 24(5). 407–409. 4 indexed citations
16.
Scott, Lucy, Jeff White, Robin Reid, & Fiona Cowie. (2005). Management of Skin Toxicity Related to the Use of ImatinibMesylate (STI571, Glivec™) for Advanced Stage GastrointestinalStromal Tumours. Sarcoma. 9(3-4). 157–160. 17 indexed citations
17.
Pentheroudakis, G., Jeff White, Jo Ann Davis, Iain Brown, & P. Vasey. (2003). Concurrent ovarian-type primary peritoneal adenocarcinoma and peritoneal choriocarcinoma. A case report and review of the literature. Gynecologic Oncology. 92(2). 697–700. 8 indexed citations
18.
White, Jeff. (2001). Lung cancer as the presenting feature of AIDS. Lung Cancer. 33(1). 81–87. 2 indexed citations
19.
White, Jeff, Alison Jones, Christopher Poole, et al.. (2000). A Multicentre Phase II Pilot Study of Epirubicin and Taxol™ (Paclitaxel) in Patients with Advanced Breast Cancer. Clinical Oncology. 12(4). 256–259. 2 indexed citations
20.
Mouriquand, P., et al.. (1995). The Kropp‐onlay procedure (Pippi Salle procedure): a simplification of the technique of urethral lengthening. Preliminary Results in eight patients. British Journal of Urology. 75(5). 656–662. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026